Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
CompletedPhase 1, Phase 2NCT00634803
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.
Study details
- Official title
- Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
- Conditions
- Opiate Dependence
- Chronic Pain
- Interventions
- Behavioral: CBT
- Drug: Buprenorphine
- Other: Educational Counseling
- Other: Physician Management
- Sponsor
- Yale University
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Start date
- 2009-09
- Primary completion
- 2015-05
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years of age or older * prescription opioid addiction criteria * moderate to severe chronic pain * seeking or interested in buprenorphine maintenance * understand English Exclusion Criteria: * methadone maintenance at a dose greater than 40 mg daily * current suicide or homicide risk * life-threatening or unstable medical problem * pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00634803